This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Centro De Immunologia Molecular. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: **Adys González Palomo: Pioneer in Pharmaceutical Innovations**
Introduction
Adys González Palomo, based in La Habana, Cuba, is an accomplished inventor known for his significant contribution to the field of pharmaceutical sciences. With a focus on innovative treatments for cancer, he has developed a patented solution aimed at enhancing therapeutic effects against certain types of tumors.
Latest Patents
Adys holds one patent titled "Pharmaceutical compositions for the treatment of tumors expressing EGFR and GM3 N-glycolyl ganglioside (NeuGcGM3)." This groundbreaking invention addresses the growing need for effective cancer treatments by targeting malignant tumors that exhibit expression of specific proteins, namely EGFR and GM3 N-glycolyl ganglioside. The pharmaceutical compositions he developed combine antibodies and/or vaccines designed to improve treatment efficacy. Furthermore, this patent encompasses methodologies for the practical application of these compositions in clinical settings.
Career Highlights
Adys González Palomo works at the prestigious Centro de Inmunología Molecular, where his research and development efforts are dedicated to advancing cancer treatment methods. Through his work, he has established himself as a key figure in the innovative health landscape, contributing to the ongoing battle against malignancies.
Collaborations
Throughout his career, Adys has collaborated with talented professionals such as Adriana Carr Perez and Kalet León Monzón. These partnerships reflect his commitment to fostering a collaborative research environment aimed at driving forward medical advancements.
Conclusion
Adys González Palomo's dedication to pharmaceutical innovation exemplifies the crucial intersection of research and practical treatment solutions in oncology. His patent not only demonstrates his ingenuity but also offers hope for enhanced therapeutic outcomes for patients facing challenging diagnoses. As advancements in pharmaceutical compositions continue to evolve, inventors like Adys play a vital role in shaping the future of medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile